Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer

This study has been completed.
Sponsor:
Collaborators:
National Cancer Institute (NCI)
Solvay Pharmaceuticals
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT00553059
First received: November 2, 2007
Last updated: September 4, 2014
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)